LB PHARMACEUTICALS INC Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q3 2024 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Lb Pharmaceuticals Inc quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q3 2024 to Q3 2025.
- Lb Pharmaceuticals Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2025 was -$3.61M, a 75.1% increase year-over-year.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)